Yángüez, E., Hunziker, A., Dobay, M. P., Yildiz, S., Schading, S., Elshina, E., . . . Stertz, S. (2018). Phosphoproteomic-based kinase profiling early in influenza virus infection identifies GRK2 as antiviral drug target. Nat Commun.
Chicago-стиль цитированияYángüez, Emilio, et al. "Phosphoproteomic-based Kinase Profiling Early in Influenza Virus Infection Identifies GRK2 As Antiviral Drug Target." Nat Commun 2018.
MLA-цитированиеYángüez, Emilio, et al. "Phosphoproteomic-based Kinase Profiling Early in Influenza Virus Infection Identifies GRK2 As Antiviral Drug Target." Nat Commun 2018.
Предупреждение: эти цитированмия не могут быть всегда правильны на 100%.